These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22615281)

  • 1. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Rolley N; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4527-33. PubMed ID: 20733039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
    Hull CM; Bader O; Parker JE; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6417-21. PubMed ID: 23027188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
    Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3578-83. PubMed ID: 20547793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
    Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress.
    Li QQ; Tsai HF; Mandal A; Walker BA; Noble JA; Fukuda Y; Bennett JE
    Mol Med Rep; 2018 May; 17(5):6585-6597. PubMed ID: 29532896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Defective Growth Pattern and Multidrug Resistance in a Clinical Isolate of Candida glabrata Using Whole-Genome Sequencing and Computational Biology Applications.
    Merdan O; Şişman AS; Aksoy SA; Kızıl S; Tüzemen NÜ; Yılmaz E; Ener B
    Microbiol Spectr; 2022 Aug; 10(4):e0077622. PubMed ID: 35867406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
    J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-Function
    Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
    mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
    Martel CM; Parker JE; Warrilow AG; Rolley NJ; Kelly SL; Kelly DE
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4920-3. PubMed ID: 20733045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
    J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ahmad S; Joseph L; Parker JE; Asadzadeh M; Kelly SL; Meis JF; Khan Z
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455247
    [No Abstract]   [Full Text] [Related]  

  • 19. A Transcriptomics Approach To Unveiling the Mechanisms of
    Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
    [No Abstract]   [Full Text] [Related]  

  • 20. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.